Oracle Clinical One and InForm alternatives for teams that want a patient-first platform

Oracle Clinical One and InForm are built around the sponsor's operations. If your study lives or dies on how participants experience it, that matters. WeGuide is a patient-first platform with eCOA, eConsent, wearables, and whitelabel mobile apps, regulatory grade, usually deployed in six weeks.

No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours.

patient engagement

Used by leading research and medical institutes.

Why research teams look for an Oracle Clinical alternative

The Oracle Clinical conversation usually splits in two directions.

Mid-market sponsors evaluating Oracle Clinical One. Oracle Clinical One consolidates EDC, CTMS, RTSM, eTMF, eCOA, eConsent, and safety into one platform, which sounds like exactly what a mid-market sponsor wants. They book a call, get a quote with enterprise pricing and a multi-month implementation runway, and realise the platform was built for top-20 pharma sponsors running hundreds of sites. For mid-market biotech, academic CROs, and investigator-led studies, the implementation complexity and contract model don't match the scale of the work.

Legacy Oracle InForm customers facing end-of-life decisions. Oracle InForm has a long history but the product direction has shifted towards Oracle Clinical One. Teams that have been running InForm for years are now weighing whether to migrate to Clinical One, move to a different enterprise platform like Medidata or Veeva, or step down to a mid-market platform that fits their actual study portfolio. For teams whose research isn't top-20 pharma enterprise, a mid-market option is often the better answer.

The other recurring issue is patient-first architecture. Oracle Clinical One is built around enterprise data capture and regulatory submissions, which is exactly what Oracle's traditional customer base needed. Participant engagement, whitelabel mobile apps, native wearable data, and continuous engagement architecture are not where Oracle has invested. Oracle's eCOA is delivered through Digital Gateway integrations with third-party vendors rather than a native patient app, which works but doesn't deliver the participant experience that modern decentralised and engagement-heavy studies need.

WeGuide is built the other way around. We're a patient engagement and clinical trial platform with a whitelabel mobile app at the centre, not an enterprise data-capture stack with eCOA bolted on through integrations. If your study is a top-20 pharma enterprise programme running Argus Safety and full Oracle infrastructure, Oracle is probably still the right tool. If your study is mid-market, academic, or engagement-heavy, keep reading.

Compare

Full comparison: WeGuide vs Oracle Clinical One

REDCap
REDCap
Primary use case
Patient engagement platform with eCOA, eConsent, wearables, registries
Enterprise clinical data capture and regulatory submission stack
Target customer
Mid-market sponsors, academic CROs, digital health programmes, registries
Top-20 pharma sponsors and large global CROs with enterprise Oracle infrastructure
Configuration model
No-code programme builder, self-service by research teams
Enterprise implementation with dedicated Oracle-certified team
Typical deployment time
6 weeks (BRACE Trial: 6,000 participants across 5 countries)
Multi-month enterprise implementation cycles
Pricing model
Project-based, all modules included
Enterprise multi-year contracts
Whitelabel mobile app
Yes, fully branded under your organisation
Oracle eCOA delivered through Digital Gateway integrations, not a native patient app
eCOA and ePRO
Native with 200+ validated instrument library
Delivered through third-party Digital Gateway integrations
eConsent
Built-in with regulatory version control
Part of Clinical One suite
Wearable integration
Native Garmin, Apple Health, Google Fit
Supported through partner integrations
Telehealth and virtual visits
Built-in video visit and virtual site features
Not a core product area
Patient registry
Built-in longitudinal registry (GenV: 100,000+ families)
Not a native use case
Employee wellbeing and population health
Built-in (Lendlease programme)
Outside the platform's scope
Pharmacovigilance
Not offered, integrates with Argus via Integration Engine
Argus Safety is a category benchmark and Oracle's core strength
EDC depth
Form Builder covers eCRF use cases, deeper capture via Integration Engine
Clinical One EDC has 20+ years of FDA submission history
UX and modern interface
Modern whitelabel participant and researcher experience
Enterprise legacy design with decades of interface heritage
Regulatory certification
TGA Class I medical device, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11 and broad Oracle regulatory compliance
Australian data residency
Yes
Available through Oracle Cloud regional infrastructure
REDCap
REDCap

Top alternatives to Oracle Clinical in 2026

Here's the shortlist of platforms most teams evaluate when they're moving off Oracle InForm or looking at Oracle Clinical One.

All-in-one platform

WeGuide combines eCOA, eConsent, data collection, and telehealth in a single platform with whitelabel apps under your own brand.

eConsent

Regulatory grade electronic consent with version tracking, re-consent workflows, digital signatures, and audit trails. REDCap doesn't have native eConsent, so teams either pair it with a second vendor or manage consent on paper.
We Guide

Screening

Screen participants against eligibility criteria directly in the app before they enrol, with branching logic and automated routing to the right study arm.

Data collection

Native eCOA and ePRO with a 200+ validated instrument library, custom forms with branching logic, and multimodal capture through forms, video, active tasks, and sensors.

Telehealth

Built in video visits, asynchronous messaging, and remote assessments that keep participants engaged with their research team between site visits.

Continuous engagement, not once-off surveys

Push notifications, educational content delivery, gamification, and a study companion that guides participants through the protocol. This is the difference between collecting data when a participant remembers and collecting data on schedule because the app is genuinely useful to them. The BRACE Trial achieved 90% adherence across 6,000 participants in five countries using this architecture. See WeGuide’s patient education module →

Push notifications and reminders

Scheduled push notifications, smart reminders, and re engagement flows that meet participants where they are on their phone rather than waiting for them to check an email.
We Guide

Study companion

A dedicated study companion that explains what's coming next, why it matters, and how to complete it ensuring participants stay informed and on track throughout the entire journey.

Educational content and gamification

Contextual educational content, progress tracking, and gentle gamification that keep participants engaged across multi year longitudinal studies.

Mobile multimodal collection

Capture the full picture of a participant's experience through forms, video, pathology, and passive sensor data all in the same app.

Forms

Native eCOA and ePRO instruments with branching logic, validation, and offline support. 200+ validated instruments ready to drop into a study.
We Guide

Video

Structured video capture for symptom diaries, gait analysis, and remote clinical assessments, stored securely against the participant record.

Pathology

Seamlessly set up integrations with your pathology providers to collect DNA or blood data from participants, streamlining the clinical data pipeline directly within the study workflow.

Sensors

Native Garmin, Apple Health, Google Fit, and FindAir integrations that sync passive wearable and sensor data straight into the study database.

Whitelabel: your study, your brand

WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of why our studies average 94% adherence.

Your brand end-to-end

Native iOS and Android apps under your organisation's name, logo, and colours not a WeGuide-branded web view.
We Guide

App store distribution

Published under your developer account on the Apple App Store and Google Play so participants download an app that clearly belongs to your institution.

Multilingual out of the box.

Translation management for multisite, multi-country studies, proven on INHERIT across multilingual communities.

Where WeGuide goes further

For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move from Veeva Clinical to WeGuide.

Patient-first platform, not data-first platform

Whitelabel mobile apps under your brand

No-code configuration without enterprise implementation teams

Deploy in weeks, not enterprise cycles

Native Garmin, Apple Health, and Google Fit

Patient registries, employee wellbeing, and population health

Accessible pricing for mid-market research

Modern UX for researchers and participants

Built for regulated research

Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.

TGA Certified

Certified Class I medical device software under the Therapeutic Goods Administration.

ISO 27001

Certified information security management covering access, audit, and incident response.

Data Hosted in Australia

Participant data is hosted in Australian data centres with sovereign data controls.

GDPR Compliant

GDPR, HIPAA, and 21 CFR Part 11 ready for multi-country and US-based studies.

Biometric Security

Participant access protected by PIN code and biometric authentication on device.

256-bit AES Encryption

All data encrypted at rest and in transit with automated backups and disaster recovery.
12x

Faster

Your own platform ready in weeks and changes are made in minutes

94%

Adherence Rates

High patient engagement and better quality data

10x

Cost Saving

Reduce financial and technology risk when creating a secure health app

200K+

Patients Impacted

With our ease of use and roll out, our apps have engaged 200k+ users

Where Oracle Health Sciences excels

Deep regulatory pedigree. Oracle Clinical and Oracle InForm have 20+ years of FDA submission history behind them. That kind of regulatory track record matters to enterprise pharma whose compliance and risk teams need well-worn vendor precedent. Oracle-sourced data has been accepted in thousands of FDA submissions, and that history is a genuine asset.

Oracle Clinical One consolidates the clinical stack. Clinical One brings EDC, CTMS, RTSM, eTMF, eCOA, eConsent, and safety together into one platform. For enterprise sponsors who want a unified Oracle-backed clinical stack with genuine cross-module integration, Clinical One is a serious platform and we won't pretend otherwise.

Argus Safety is the pharmacovigilance benchmark. For drug safety case management and regulatory reporting, Argus Safety is the category leader across global pharma. WeGuide does not offer pharmacovigilance capabilities, and if your study needs Argus-grade safety case management, Oracle is the right tool. We'll tell you that upfront.

Enterprise infrastructure and scale. Oracle's broader database and cloud infrastructure sits behind the clinical platform. For enterprise sponsors whose procurement and IT teams need vendor stability, global data residency options, and deep integration with existing Oracle infrastructure, the Oracle clinical stack benefits from the parent company's scale.

Global pharma adoption. Oracle Clinical, InForm, and Clinical One have deep installed bases across top-20 pharma. For sponsors whose therapeutic area teams have already worked with Oracle software for years, there's real value in vendor continuity and institutional knowledge.

If your study is a top-20 pharma late-stage enterprise programme running Argus Safety and full Oracle infrastructure, Oracle is a legitimate choice and WeGuide does not replace the enterprise clinical data stack. We're a patient engagement and mid-market clinical trial platform, not an enterprise EDC replacement.

WeGuide works alongside Oracle Clinical One

If your enterprise portfolio runs Oracle Clinical One for core EDC, CTMS, or Argus Safety for pharmacovigilance, you don't have to rip it out to use WeGuide for the participant-facing layer. Our Integration Engine connects to Oracle Clinical One and InForm through their APIs, so Oracle handles enterprise data capture and safety case management while WeGuide runs whitelabel patient engagement, eCOA, eConsent, wearables, and registries. Hybrid stacks are common with teams migrating off legacy InForm or running dual-platform architectures.

How the switch works

For teams that are evaluating Oracle Clinical One or migrating off legacy Oracle InForm, or for Oracle customers who want to layer WeGuide on top of the existing stack, here's how onboarding typically plays out.

Discovery Call

A 30-minute conversation with one of our research delivery team. We look at your protocol, your current Oracle setup, and what's actually blocking you. No sales pitch.

Study Configuration

Our team works alongside yours to configure the study in WeGuide. If you're keeping Oracle Clinical One for core EDC or Argus for safety, we configure the Integration Engine at this stage. Typical timeline: two to four weeks.

We Guide

Participant Onboarding

The whitelabel app goes live under your organisation's brand. Research coordinators invite participants, and consent flows, eCOA instruments, and engagement templates are ready.

Ongoing Support

You get a named research delivery contact, not an Oracle certified consultant contract. We stay involved for the life of the study.

Case studies: research teams that moved faster than enterprise Oracle software allows

BRACE Trial (Murdoch Children's Research Institute)

A global randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity. Launched across five countries with 6,000+ participants in six weeks during the pandemic. Adherence exceeded 90%. An Oracle Clinical One implementation wouldn't have finished configuration in that window.

GenV (Generation Victoria)

A population health study tracking more than 100,000 Victorian families from birth. Longitudinal registry work at this scale sits outside Oracle Clinical One's scope. The whitelabel family facing app is the reason retention has held across multiple years.

INHERIT

An employee wellbeing deployment across a global workforce, using WeGuide for participant reported outcomes, engagement content, and population health analytics. The kind of programme that sits entirely outside enterprise pharma software scope.

Helping researchers transform ideas into discoveries.

Hear what our clients have to say!

"GenV trusted WeGuide to run a multi-year population health study across more than 100,000 Victorian families. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years.""
Susan Clifford
Susan Clifford
Senior Research Officer
GEN V logo
“The main benefit of WeGuide is its convenience. I can’t imagine how we would follow thousands of participants and collect their data without WeGuide!”
Kaya Gardiner
Kaya Gardiner
Trial Project Manager
Murdoch children Research Institute
"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."
Emma Photo
Emma Weatherley
Managing Director
FSHD Global
"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."
KATE Cranwell
Kate Cranwell
Manager
Western Health
"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."
Testimonial Photo
Paul Eleftheriou
Chief Medical Officer
Western Health

Questions

Straight answers on how WeGuide compares to Oracle Clinical One and InForm, what migration looks like, and when staying on Oracle is the right call.

Contact us

Is WeGuide a full replacement for Oracle Clinical One?

Honestly, no, and we'll tell you that upfront. For large pharma running Argus Safety, Clinical One, and the full Oracle enterprise stack across therapeutic area teams, WeGuide is not a drop in replacement for the Oracle clinical data and safety infrastructure. For mid-market sponsors, academic institutions, and CROs looking for a patient first platform without enterprise implementation timelines and multi-year contracts, WeGuide is the right choice. Many of the teams we work with evaluated Clinical One first, concluded it wasn't the right fit for their scale, and chose WeGuide for the same protocol.

Does WeGuide replace Argus Safety for pharmacovigilance?

No. Argus Safety is the industry benchmark for drug safety case management and regulatory reporting, and WeGuide does not offer pharmacovigilance capabilities. If your study needs Argus grade safety case management, Oracle remains the right tool. WeGuide integrates with Argus through the Integration Engine, so sponsors running both can keep Argus for safety and use WeGuide for the participant-facing layer.

Can WeGuide integrate with Oracle InForm or Clinical One?

Yes. Our Integration Engine connects to Oracle InForm and Oracle Clinical One through their APIs, so you can keep Oracle for core EDC, CTMS, or safety and layer WeGuide on top for participant experience, eCOA, eConsent, wearables, and registries. Hybrid architectures are common with teams running both platforms.

How does Oracle's eCOA compare to WeGuide's?

Oracle collects eCOA data through Digital Gateway integrations with third-party vendors. That works for enterprise sponsors who already have procurement relationships with specialist eCOA providers, but it adds integration complexity and splits the participant experience across multiple systems. WeGuide's eCOA is native, integrated into the Form Builder with a library of 200+ validated instruments, and runs inside a single whitelabel patient app alongside engagement content, eConsent, and wearable data. Different philosophies for different studies.

How does pricing compare?

Oracle Clinical One is enterprise priced with multi-year contracts that assume a top-20 pharma customer profile. WeGuide is project based and scales to the study's actual complexity, with every module included in the core licence. For mid market sponsors and academic research, WeGuide is typically significantly less expensive, and the implementation cost is lower because you don't need a certified Oracle consultant to stand up the platform.

We're migrating off legacy Oracle InForm. What's involved?

For teams facing end of life decisions on Oracle InForm, we handle data migration through the Integration Engine. Typical timeline is weeks, not months, because the no code programme builder lets your research team configure the new study directly without waiting for an enterprise implementation project. We'll look at your current InForm setup on the discovery call and map out exactly what migration looks like for your specific protocol.

Never miss an update

Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.

By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.

Thank you! Your submission has been received!
Oops! Something went wrong. Please try again.

Certified and Compliant by Leading Standards